Aurora Cannabis Inc. (ACB)

Market Cap	184.17M
Revenue (ttm)	154.45M
Net Income (ttm)	-1.28B
Shares Out	340.99M
EPS (ttm)	-5.61
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,641,929
Open	0.535
Previous Close	0.560
Day's Range	0.530 - 0.570
52-Week Range	0.530 - 2.280
Beta	3.00
Analysts	Hold
Price Target	3.00 (+455.45%)
Earnings Date	Jun 6, 2023

About ACB

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Miguel Martin
• Employees: 1,338
• Stock Exchange: NASDAQ
• Ticker Symbol: ACB

Financial Performance

In 2022, ACB's revenue was 221.34 million, a decrease of -9.75% compared to the previous year's 245.25 million. Losses were -1.72 billion, 146.5% more than in 2021.

Financial numbers in CAD

Analyst Forecast

According to one analyst, the rating for ACB stock is "Hold" and the 12-month stock price forecast is $3.0.

Price Target

$3.0

(455.45% upside)

Analyst Consensus: Hold